View in EDS PDF Full Text

The GOFURTGO Study: AGITG Phase II Study of fixed dose rate gemcitabine-oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancer.

Saved in:
Bibliographic Details
Title: The GOFURTGO Study: AGITG Phase II Study of fixed dose rate gemcitabine-oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancer.
Authors: Goldstein, D1, Spry, N2, Cummins, M M3, Brown, C3, van Hazel, G A2, Carroll, S4, Selva-Nayagam, S5, Borg, M5, Ackland, S P6, Wratten, C6, Shapiro, J7, Porter, I W T8, Hruby, G9, Horvath, L9, Bydder, S10, Underhill, C11, Harvey, J12, Gebski, V J3
Source: British Journal of Cancer. 1/3/2012, Vol. 106 Issue 1, p61-69. 9p. 1 Diagram, 5 Charts, 3 Graphs.
Database: Academic Search Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 70096755
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The GOFURTGO Study: AGITG Phase II Study of fixed dose rate gemcitabine-oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Goldstein%2C+D%22">Goldstein, D</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Spry%2C+N%22">Spry, N</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Cummins%2C+M+M%22">Cummins, M M</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Brown%2C+C%22">Brown, C</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22van+Hazel%2C+G+A%22">van Hazel, G A</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Carroll%2C+S%22">Carroll, S</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Selva-Nayagam%2C+S%22">Selva-Nayagam, S</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Borg%2C+M%22">Borg, M</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Ackland%2C+S+P%22">Ackland, S P</searchLink><relatesTo>6</relatesTo><br /><searchLink fieldCode="AR" term="%22Wratten%2C+C%22">Wratten, C</searchLink><relatesTo>6</relatesTo><br /><searchLink fieldCode="AR" term="%22Shapiro%2C+J%22">Shapiro, J</searchLink><relatesTo>7</relatesTo><br /><searchLink fieldCode="AR" term="%22Porter%2C+I+W+T%22">Porter, I W T</searchLink><relatesTo>8</relatesTo><br /><searchLink fieldCode="AR" term="%22Hruby%2C+G%22">Hruby, G</searchLink><relatesTo>9</relatesTo><br /><searchLink fieldCode="AR" term="%22Horvath%2C+L%22">Horvath, L</searchLink><relatesTo>9</relatesTo><br /><searchLink fieldCode="AR" term="%22Bydder%2C+S%22">Bydder, S</searchLink><relatesTo>10</relatesTo><br /><searchLink fieldCode="AR" term="%22Underhill%2C+C%22">Underhill, C</searchLink><relatesTo>11</relatesTo><br /><searchLink fieldCode="AR" term="%22Harvey%2C+J%22">Harvey, J</searchLink><relatesTo>12</relatesTo><br /><searchLink fieldCode="AR" term="%22Gebski%2C+V+J%22">Gebski, V J</searchLink><relatesTo>3</relatesTo>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22British+Journal+of+Cancer%22">British Journal of Cancer</searchLink>. 1/3/2012, Vol. 106 Issue 1, p61-69. 9p. 1 Diagram, 5 Charts, 3 Graphs.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=70096755
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/bjc.2011.526
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 9
        StartPage: 61
    Titles:
      – TitleFull: The GOFURTGO Study: AGITG Phase II Study of fixed dose rate gemcitabine-oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Goldstein, D
      – PersonEntity:
          Name:
            NameFull: Spry, N
      – PersonEntity:
          Name:
            NameFull: Cummins, M M
      – PersonEntity:
          Name:
            NameFull: Brown, C
      – PersonEntity:
          Name:
            NameFull: van Hazel, G A
      – PersonEntity:
          Name:
            NameFull: Carroll, S
      – PersonEntity:
          Name:
            NameFull: Selva-Nayagam, S
      – PersonEntity:
          Name:
            NameFull: Borg, M
      – PersonEntity:
          Name:
            NameFull: Ackland, S P
      – PersonEntity:
          Name:
            NameFull: Wratten, C
      – PersonEntity:
          Name:
            NameFull: Shapiro, J
      – PersonEntity:
          Name:
            NameFull: Porter, I W T
      – PersonEntity:
          Name:
            NameFull: Hruby, G
      – PersonEntity:
          Name:
            NameFull: Horvath, L
      – PersonEntity:
          Name:
            NameFull: Bydder, S
      – PersonEntity:
          Name:
            NameFull: Underhill, C
      – PersonEntity:
          Name:
            NameFull: Harvey, J
      – PersonEntity:
          Name:
            NameFull: Gebski, V J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 01
              Text: 1/3/2012
              Type: published
              Y: 2012
          Identifiers:
            – Type: issn-print
              Value: 00070920
          Numbering:
            – Type: volume
              Value: 106
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: British Journal of Cancer
              Type: main
ResultId 1